Falcon's Beyond Global, Inc. (FBYD) - Q1 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2025. Falcon's Beyond Global, Inc. operates at the intersection of content, technology, and experiences through three primary divisions: Falcon's Creative Group (FCG), Falcon's Beyond Destinations (FBD), and Falcon's Beyond Brands (FBB). The company is classified as a non-accelerated filer, smaller reporting company, and emerging growth company. As of May 15, 2025, the company had 37.2 million Class A and 83.8 million Class B shares outstanding.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Revenue | $1.7 million | $1.5 million |
| Net Loss | $(8.1) million | $114.0 million (Income) |
| Operating Loss | $(6.3) million | $(5.3) million |
| Cash from Operations | $0.9 million | $(3.8) million |
| Cash and Equivalents | $1.1 million | $1.0 million |
| Total Debt | $41.0 million | $41.2 million |
| Working Capital Deficiency | $(39.1) million | N/A |
Note: Q1 2024 net income was significantly inflated by a $118.6 million non-cash gain from the change in fair value of earnout liabilities.
Material Changes vs. Prior Period
- Revenue: Increased by $0.2 million (12.6%) driven by shared services and a new attractions maintenance contract.
- Net Loss: Shifted from a $114.0 million net income in Q1 2024 to an $8.1 million net loss in Q1 2025. The prior year income was largely due to a one-time $118.6 million gain on earnout liabilities, which did not recur.
- Equity Method Investments: The share of loss from equity method investments increased to $4.1 million (loss) from $1.2 million (gain) in the prior year. This was primarily driven by a $4.6 million loss from FCG, attributed to decreased revenues and margin compression on long-term contracts.
- Transaction Expenses: Increased to $1.5 million from $7,000, related to a proposed underwritten offering that was not completed.
- Interest Expense: Increased to $1.3 million from $0.3 million due to higher outstanding debt and interest rates.
Guidance, Outlook, Risks, and Contingencies
Going Concern: Management has raised substantial doubt about the company's ability to continue as a going concern for the next twelve months. The company has a working capital deficiency of $39.1 million and $10.4 million in debt maturing within 12 months. It currently lacks sufficient cash to meet liabilities and fund operations without additional financing.
Liquidity: The company relies on distributions from equity method investments, debt, and equity raises. It has $0.9 million available under credit lines and $1.1 million in cash.
Legal Proceedings: The company is involved in litigation with Guggenheim Securities regarding $11.1 million in alleged fees for the Business Combination. The company has denied liability and filed counterclaims. A trial readiness date is set for June 28, 2025.
Internal Controls: The company identified material weaknesses in internal controls over financial reporting, which remain unremediated as of March 31, 2025.
Subsequent Events: In May 2025, the company acquired assets and IP from Oceaneering Entertainment Systems for $1.5 million and assumed a lease for a 106,000 sq. ft. facility. It also has an option to acquire additional inventory for $7.5 million.
Investor Verification Checklist
- Capital Raise Status: Verify if the company has secured the additional debt or equity financing required to address the $39.1 million working capital deficiency and $10.4 million in near-term debt maturities.
- Guggenheim Litigation: Monitor the outcome of the lawsuit and counterclaims regarding the $11.1 million accrued transaction fees.
- FCG Performance: Assess the sustainability of FCG's revenue decline and the impact of the QIC Dragon Ball contract timing on future cash flows.
- Internal Control Remediation: Review progress on remediation plans for material weaknesses in financial reporting controls.
- Debt Covenants: Confirm compliance with debt covenants given the current liquidity constraints and recent loan amendments extending maturity dates to May 2025.